These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 8422715)

  • 1. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
    O'Malley JP; Ziessman HA; Chantarapitak N
    Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
    Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
    Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
    Mustafa S; Elgazzar AH
    J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function.
    Taylor A; Ziffer JA; Eshima D
    Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
    Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
    J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
    Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
    Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
    Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
    Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the "integral spleen" method of radiorenogram analysis and a baboon model to compare the diagnostic usefulness of technetium-99m-diethylenetriamine pentaacetic acid to that of various technetium-99m-mercaptoacetyltriglycene formulations and iodine-123-hippuran.
    Dormehl IC; Van Wyk A; Pilloy W; Maree M; Knoesen O; De Winter R; Jacobs L; Hoppe HC
    Am J Physiol Imaging; 1989; 4(1):23-7. PubMed ID: 2522307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of early tubular extraction in the first minute of Tc-99m MAG3 renal transplant scintigraphy.
    Lin E; Alavi A
    Clin Nucl Med; 1998 Apr; 23(4):217-22. PubMed ID: 9554192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Tc-99m MAG3 and Tc-99m DTPA scintigraphy in neonates.
    Taylor A; Clark S; Ball T
    Clin Nucl Med; 1994 Jul; 19(7):575-80. PubMed ID: 7924094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
    Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
    Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.
    Russell CD; Thorstad B; Yester MV; Stutzman M; Baker T; Dubovsky EV
    J Nucl Med; 1988 Jul; 29(7):1189-93. PubMed ID: 2969040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical.
    Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN
    Clin Nucl Med; 1994 May; 19(5):446-51. PubMed ID: 8039322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical.
    Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN
    Clin Nucl Med; 1994 Apr; 19(4):314-20. PubMed ID: 8004863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the normal range of furosemide half-clearance times when using Tc-99m MAG3.
    Rossleigh MA; Thomas MY; Moase AL
    Clin Nucl Med; 1994 Oct; 19(10):880-2. PubMed ID: 7805322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background correction in estimating initial renal uptake. Comparison between Tc-99m MAG3 and Tc-99m DTPA.
    Inoue Y; Machida K; Honda N; Takahashi T; Mamiya T
    Clin Nucl Med; 1994 Dec; 19(12):1049-54. PubMed ID: 7874800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of renal function with technetium-99m MAG3.
    Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
    J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
    Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
    Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA].
    Torizuka K; Ishibashi A; Ikekubo K; Yamamoto K; Nishibuchi S
    Kaku Igaku; 1994 Feb; 31(2):183-98. PubMed ID: 8121074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.